Nā Laina Lyspro - kaomi ʻōlelo * hoʻohana no ka hoʻohana ʻana

hoʻonā no ka hoʻolālā intravenous a me ka subcutaneous

1.0 ml o ka hoʻonā ʻana no ka hana intravenous a subcutaneous e pili ana:
mea waiwai: Lyspro Insulin 100 ME (3.47 mg),
nā mea hoʻowalewale: zinc oxide 25 μg, disubstituted sodium phosphate 1.88 mg, glycerol 16 mg, metacresol 3.15 mg, hydrochloric acid i ka pH 7.0-7.8, sodium hydroxide to pH 7.0-7.8, wai no ka hōʻemi a hiki i ka 1.0 ml.

Nā ʻāpana ʻokoʻa ʻokoʻa.

ʻO nā waiwai Pharmacological

ʻO Lyspro insulin kahi mea e like me ka DNA recombinant analogue o ka hana kanaka o ka insulin. Kūʻokoʻa mai ka ʻenekema o ke kanaka i ka hōʻano hope o nā waikela amino i nā kūlana 28 a me 29 o ka kaulahao B B.

Lapaʻau lāʻau
ʻO ka hana nui o ka lyspro insulin ʻo ia ka hoʻoponopono ʻana o nā hana kū ka pehu. Eia kekahi, he ia nā hopena anabolic a me nā anti-catabolic i nā kiko kino o nā kino. I ka kiko o ka uaua, loaʻa ka nui o nā mea e pili ana i ka glycogen, ka momona o ka momona, ka glycerol, ke piʻi ʻana o ka synthesis protein a me ka hoʻonui ʻana i ka ʻai o nā waikawa amino, akā, he make i ka glycogenolysis. gluconeogenesis, ketogenesis. lipolysis, protein catabolism a me ka hoʻokuʻu o nā waikawa amino.
Ua hōʻike ʻia ua like ka like o ka insulin lyspro i ka insinolar a kanaka, akā ua wikiwiki koke kāna hana a kū i ka manawa pōkole.
Hōʻike ʻia ka insulin Lyspro e ka wikiwiki wikiwiki o ka hana (ma kahi o 15 mau minuke), no ka mea, he nui kona emi ʻana, a hiki iā ia ke lawelawe koke ʻia ma mua o ka ʻai (0-15 mau minuke ma mua o ka ʻai), ʻaʻole e like me ka insulin kaohi pōkole hana maʻamau. Hoʻopuka wikiwiki ʻo Lyspro i kona hopena a loaʻa i ka lōʻihi o ka hana (mai 2 a 5 mau hola), akā ke hoʻohālikelike ʻia me nā insulin kanaka maʻamau.
I ka maʻi me ka type 1 a me ka type 2 diabetes mellitus, ʻo ka hyperglycemia e loaʻa ana ma hope o ka ʻai ʻana me ka insulin lyspro e emi nui ana i ka hoʻohālikelike ʻia me ka insulin kanaka.
E like me ka hoʻomākaukau ʻana i nā insulin a pau, hiki i ka lōʻihi o ka hana a ka lyspro insulin i like ʻole i nā mea maʻi a i ʻole nā manawa like ʻole i ka mea like me ka hilinaʻi ʻana i ka maʻi, ka lūlū, ka wai ʻai, ke ʻano o ke kino a me ka hana kino.
ʻO nā hiʻohiʻona pharmacodynamic o ka insulin lyspro i nā keiki a me nā wā'ōpiopio ua like nā mea i nānā ʻia i nā pākeke.
ʻO ka hoʻohana ʻana o ka insulin lyspro i nā mea maʻi me ka maʻi diabetes type 1 a me ke ʻano 2 me ka hoʻokaʻawale ʻana i nā kao o nā episekole o ka hypoglycemia nocturnal i hoʻohālikelike ʻia me ka hoʻōla ʻana o ka insulin kanaka. ʻO ke kūlike o ka glucodynamic i ka insulin lispro he kūʻokoʻa o ka renal a hepatic function.

Lapaʻau lāʻau
Ma hope o ka lawelawe ʻākala, ua hoʻopili koke ʻia ka insulin Lyspro a hiki i ke kaʻi ʻana o ka plasma kiʻekiʻe ma hope o 30-70 mau minuke.
Me ka hoʻokele subcutaneous, ʻo ka hapalua o nā ola o ka insulin lispro ma kahi o 1 hola.
I nā mea maʻi me ka hiki ʻole o ka renal, ʻoi aku ka nui o ka nui o ke komo ʻana o ka inea lyspro i hoʻohālikelike ʻia me ka insulin manu kīnā. I nā mea maʻi me ka maʻi type 2, he ʻokoʻa nā pharmacokinetic ma waena o ka insulin lispro a me ka soluble o ke kanaka kūʻokoʻa i ka hana ʻoi.
ʻO nā mea maʻi me ka maʻi hepatic i loaʻa i kahi helu kiʻekiʻe o ka absorption a me ka wikiwiki wikiwiki i ka insulin lispro i hoʻohālikelike ʻia i ka insulin kanaka kīnā.

E hoʻohana i ka wā hāpai a i ka wā paʻakikī

Kahawai
ʻO nā helu nui e pili ana i ka hoʻohana ʻana i ka insulin lispro i ka wā hapai e hōʻike nei i ka loaʻa ʻole o kahi hopena kūpono ʻole o ka lāʻau lapaʻau i ka wā e hāpai ai a i ke ʻano o ka pēpē a me kahi keiki hou.
I ka wā hāpai, ʻo ka mea nui i ka mālama pono i ka mālama glycemic maikaʻi i nā mea maʻi me ka maʻi diabetes e loaʻa nei ka mālama ʻana me ka insulin. Ka pono o ka insulin e hoʻemi i ka wā o ka trimester mua a hoʻonui i ka wā i ka trimesters lua a me ke kolu. I ka wā a ma hope o ka hānau ʻana, hāʻule paha nā koi o ka insulin. ʻO ka poʻe maʻi me ka maʻi maʻi e kipa e pili i ke kauka inā hiki ke hāpai ʻia a i ʻole ke hoʻolālā ʻana. Ma ka hihia o ka hapai i nā maʻi me ka maʻi maʻi, ʻo ka mea nui ka nānā pono ʻana i ka neʻe o ka glucose i loko o ke koko, a me ka kūlana aoao o ke olakino.
ʻ periodmeʻa
ʻO nā mea maʻi i ka wā o ka ʻōpiopio e pono ai e hoʻoponopono i ke hoʻoponopono ʻia ka dosage o ka insulin, ka meaʻai, a i ʻole ʻelua.

ʻLoe a me ke kākele

Hoʻoholo ʻia ka hopena o ka lāʻau Insulin Lyspro e ke kauka hoʻokahi, ma muli o ka neʻe o ka glucose i ke koko. ʻO ke ʻano o ka noho ʻana o ka ʻona insulin e kū hoʻokahi.
Hiki ke mālama ʻia ka Insulin Lyspro i ka manawa ma mua o nā meaʻai (0-15 mau minuke ma mua o ka ʻai). Inā pono, hiki ke lawelawe ʻia ka lāʻau Insulin Lyspro ma hope koke o ka ʻai ʻana.
Pono ka wela o ka lāʻau lapaʻau i ka mahana o ka lumi.
ʻO ka lāʻau Insulin Lyspro e pono e lawelawe ʻia ma ka ʻākala subutaneus a i ʻole hoʻokō subcutaneous ka lōʻihi me kahi pulu insulin. Inā pono (ketoacidosis, maʻi maʻi, ka manawa ma waena o ka hana a i ka wā postoperative) hiki ke lawelawe ʻia ka lāʻau lapaʻau ʻo Insulin Lyspro.
Pono e paʻi ʻia ka Subcutaneous i loko o ka poʻohiwi, ka ʻūhā, ka ʻūhā a me ka ʻōpū paha. Pono e hoʻololi ʻia nā wahi i ʻōlelo ʻia a hoʻohana ʻia kahi wahi like ʻole ma kahi o 1 manawa i hoʻokahi mahina. Me ka hoʻokolohua kūlike o ka lāʻau Insulin Lyspro, pono e mālama pono i ka mālama ʻana i ka lāʻau lapaʻau e komo ana i ka moku koko. Ma hope o ka loaʻa ʻana, ʻaʻole pono e ʻā ʻia ka pūnaewele inikua. Pono e hoʻomaʻamaʻa ʻia ka mea maʻi i ka ʻenehana injection ʻoiaʻiʻo.

Nā ʻōkuhi no ka hoʻokō o ka lāiwi Insulin lispro
a) hoʻomākaukau no ka hoʻomaka ʻana
ʻO ke ʻano o ka lāʻau Insulin Lyspro e pono e papala a me ka ʻulaʻula ʻole. Mai hoʻohana i kahi hopena o ka Insulin Lyspro inā he ao, he mānoanoa, ʻōmaʻomaʻo, ʻomaʻomaʻo a i ʻole ke nānā ʻia nā mea ikaika.
Ke kau nei i ka pahu pahu i ka penehina syringe, e hoʻopili i ka pono me ka hoʻokomo ʻana i ka insulin, e hāhai i nā ʻōlelo a ka mea hana hana e hoʻopili ʻia me kēlā me kēia peni syringe. Hiki ke hoʻohana ʻia nā cartridges me Insulin Lyspro me nā penikala syringe EndoPen i hana ʻia e Beijing Gangan Technology Co., Ltd., China. ʻAʻole hiki ke hoʻohana ʻia nā Cartridges me nā penikala syringe no ka hoʻohana mau ʻana, ʻoiai ke kūpaʻa ʻia ana ka pololei o ka make ʻana o ka lāʻau lapaʻau wale nō no nā peni ʻo nā syringe i luna nei.
keʻa d)
1. holoi i kou lima.
2. Koho i kahi pūnaewele wae.
3. E hoʻomākaukau i ka ʻili ma ka wahi i ʻōlelo ʻia e like me ke kauka ʻana e kāu kauka.
4. Holo i ka pāpale pale pale mai ka pono.
5. Hoʻopili i ka ʻili.
6. E hoʻokomo i kahi jarī subcutaneously a hana i ka ʻōlelo lapaʻau e like me ke kuhikuhi ʻana no ka hoʻohana ʻana i ka peni syringe.
7. E hoʻolei i ka nūpepa a hoʻomoʻi mālie i ka pāngo injection me ka lehelehe kāwili no kekahi mau kekona. Mai ʻōpala i kahi kahua wili.
8. E hoʻohana ana i ka pū ʻili waho, e wehe i ka pūpū a hoʻokuʻu aku.
9. E kau i ka pāpale ma ka peni syringe.
c) Ka hoʻokele o ka insulin
ʻO ka injections intravenous o ka lāʻau Insulin Lyspro e pono e hana e like me ka hana maʻamau maʻamau o ka injections intravenous, no ka laʻana, ka hana bolus intravenous a i ʻole ka hoʻohana ʻana i kahi ʻōnaehana infusion. I kēia hihia, pono pinepine ia e kaohi i ka ʻike o ka glucose i ke koko.
ʻO nā pūnaehana infusion me nā kikowaena mai ka 0.1 IU / ml i ka 1.0 IU / ml o ka lālani insulin i ka 0.9% kūkaʻi sodium chloride a i ʻole 5% dextrose solution e paʻa i ka lumi lumi no 48 mau hola.
d) ʻO ka hoʻokele subcutaneous o ka insulin e hoʻohana ana i kahi pami insulin
No ka hoʻolauna ʻana i ka lāʻau Insulin Lyspro, hiki iā ʻoe ke hoʻohana i nā kīʻaha - he ʻōnaehana no ka hoʻomau ʻana o ka hoʻomaloka kūloko o ka insulin me ka hōʻailona CE. Ma mua o ka lawelawe ʻana i ka insulin lyspro, e maopopo he kūpono ʻo kahi pākēke. Pono ʻoe e hahai i nā ʻōlelo i hele mai me ka paukena. E hoʻohana i kahi kōhao kūpono a me ka catheter no ka paipa. Pono e hoʻololi ʻia ka hākena insulin e like me nā ʻōlelo i hāʻawi ʻia me kēia pahu. I ka hihia o kahi hanana hypoglycemic, ua pau ka hoʻokele ʻana a hiki i ka hoʻonā ʻana o ka hanana. Inā hōʻike ʻia kahi haʻahaʻa o ka glucose i ke koko, a laila pono e hōʻike i ke kauka e pili ana i kēia a hoʻolako no ka hoʻokaʻawale a i ʻole nā hana hoʻomehana insulin. ʻO kahi pōpoki pāpaʻi a i ʻole kahi poloka i ka ʻōnaehana hoʻokele hiki i ka ulu wikiwiki ʻana i ka hoʻoliʻi glucose. I ka hihia o ka kānalua o ka hana i ka hāʻawi ʻana i ka insulin, pono ʻoe e hahai i nā ʻōkuhi a, inā pono, e hoʻomaopopo i ke kauka.
Ke hoʻohana nei i kahi pākeke, ʻaʻole pono e hui pū ʻia ka lāʻau Insulin Lyspro me nā insulins ʻē aʻe.

Nā hopena hopena

Hypoglycemia ʻo ka hopena maʻamau loa i makemake ʻia i ka mālama ʻana i ka insulin i nā mea maʻi me ka maʻi maʻi. Hiki i ka hypoglycemia koʻikoʻi ke alakaʻi i ka nalowale o ka ʻike (hypoglycemic coma) a. i nā hihia kūʻokoʻa, i ka make.
Loaʻa ka maʻi maʻi kūloko kūloko kūloko i ke ʻano o ka ʻulaʻula, ke kuikahi, a me ka ʻaihue paha paha ma ka kahua i ʻōlelo ʻia. ʻO ka maʻamau, nalo kēia mau hōʻailona i loko o kekahi mau lā a i ʻole hebedoma. ʻOi aku ka lōʻihi e ʻike pinepine ai kūloko kūlike maʻamau, inā hiki ke hōʻeha i ka minamina a puni ka maʻi o ka kino, urticaria, angioedema, fever, ka manawa pōkole o ka hanu, hoʻoemi ʻia ke koko, tachycardia. hoʻonui hoʻonui ʻia. ʻO nā hihia koʻikoʻi o nā maʻi maʻamau e hiki ai ke hoʻoweliweli i ke ola.
E hoʻomohala paha ka pūnaewele maʻi paluanalle.
Nā leka uila kīnā:
Ua ʻike ʻia nā ala o ka hoʻomohala o ka edema, ka mea i hoʻomau ʻia ma hope o ka hoʻohaʻahaʻa wikiwiki ʻana i ka hoʻoliʻiliʻi o ke koko i ka wā o ke kuʻina ʻana me ka hoʻomohala ʻana i ka glycemic control unaʻi (ʻike i ka ʻāpana "Kūlana Kūlana").

Ke keu

Nā Hoʻomaka ua hele ʻia he overdose me ka hoʻomohala ʻana i nā hōʻailona o ka hypoglycemia: lethargy, hoʻonui nui ʻana, nā mālamalama, ka pōkole, ka nui, tachycardia, ka ʻeha, ka dizziness, ka luaʻi ʻana, ka haunaele.
Lāʻau: Hoʻopau nā kuʻekuʻe hypoglycemic episode e ka ingestion o ka glucose a me nā mea momona ʻē aʻe, a i ʻole nā huahana i loaʻa i ke kōpaʻa (ua ʻōlelo ʻia e loaʻa mau i ka 20 g o ka glucose me ʻoe).
Ke hoʻoponopono nei i ka hypoglycemia moderately hiki ke lawe ʻia ma ka hoʻohana ʻana i ka hana intramuscular a i ʻole subcutaneous o glucagon, i ukali ʻia e ka nānā ʻana o nā hāmeʻe ma hope o ka hoʻokau ʻana o ke ʻano o ka mea maʻi. Hōʻeha ʻia nā mea maʻi ʻaʻole i pane ʻole i ka glucoseagon me kahi hopena dextrose (glucose) i loko o ka intravenously.
Inā hele ka mea maʻi i ka coma, a laila hoʻomalu ʻia ka glucagon intramuscularly a i ʻole subcutaneously. Ke hala ʻole o glucagon a inā ʻaʻohe hopena i kona hoʻomaka ʻana, pono ia e lawelawe i ka hopena o ka dextrose intravenously. Ma hope koke o ka hoʻonui ʻana i ka ʻike, pono e hāʻawi ʻia ka mea maʻi i nā meaʻai momona.
Hiki ke koi hou ʻia ka nui o nā pale kāohi a me ka nānā ʻana i ka mea maʻi, no ka mea he hiki ke hoʻomaha iho i ka hypoglycemia.
E pili ana i ka hypoglycemia i hoʻoneʻe ʻia he mea pono e hoʻomaopopo i ke kauka komo.

Hoʻopili pū me nā lāʻau ʻē aʻe

Ua hōʻemi ʻia ka nui o ka hopena hypoglycemic i ka wā e hoʻohana pū ʻia me nā huaʻala i lalo: nā maʻi kūlohelohe o ka waha, glucocorticosteroids, nā iodine e pili ana i ka hormone thyroid, danazol, β₂-adrenomimetics (e.g., ritodrin, salbutamol, terbutaline), antidepresan tricyclic, diuretics thiazide, chlorprotixen, diazoxide, isoniazid, lithium carbonate, acid nicotinic, phenothiazine derivatives.
Hoʻonui ka koʻikoʻi o ka hana hypoglycemic i ka wā e hoʻohana pū ʻia me nā huaʻala iā ia iho: nā beta-blockers, ethanol a me nā ethanol e loaʻa ana, nā anabolic steroids, fenfluramine, guanethidine, tetracyclines, wahaʻeha hypoglycemic oral, salicylates (e.g., acetylsalicylic acid antioxidants, sulfonamides, sulfonamides ), angiotensin e hoʻohuli ana i ka pale o ka enzyme (captopril, enalapril), octreotide, angio receptor antagonist Tenzin II.
Inā pono ʻoe e hoʻohana i nā lāʻau lapaʻau ʻē aʻe, i ka hoʻohui ʻana i ka insulin, pono ʻoe e kamaʻilio i kāu kauka (e ʻike i ka ʻāpana "Nā ʻōkuhi kūikawā").

Nā ʻōlelo kikoʻī

ʻO ka hoʻoneʻe ʻana o ka mea maʻi i kahi ʻano ʻē aʻe a i ʻole ka hoʻomākaukau ʻana i ka insulin e pono ai ma lalo o ka mākaʻi loea koʻikoʻi. ʻO nā loli i ka hana, hōʻailona (hana), ʻano maʻamau (maʻamau, NPH, etc.), nā ʻenemi (holoholona, ke ʻano kanaka, mea hoʻohālike o ka insulin kanaka) a me / a i ʻole nā ʻano hana (DNA recombinant insulin a i ʻole insulin o ka hoʻomaka o ka holoholona) hiki ke alakaʻi i ka pono no kahi loli ka uku.
I ka poʻe maʻi me ka hopena o ka hypoglycemic ma hope o ka hoʻoneʻe ʻana mai ka maʻi holoholona i loaʻa i ka insulin o ke kanaka, ua hoʻomaka ʻia a he ʻole paha nā hōʻailona mua o ka hypoglycemia e like me nā mea i ʻike ʻia me ko lākou insulin mua. Pono e noʻonoʻo ma ka hopena o ka hopena o ka pharmacodynamics o nā kaila o ka hana wikiwiki o ka insulin manu, e hiki iā ia ke hoʻomohala ma hope o ka hōʻuluʻulu ʻana o ka mea hoʻonaninani insulin wikiwiki hou ma mua o ka hoʻohana ʻana o solulle i ka insulin kanaka.
No ka poʻe maʻi e loaʻa ana i nā hana pōkole a me nā basulins, pono e koho i ke ʻano o nā insulins ʻelua i mea e hoʻokō ai ka ʻike maikaʻi ʻana o ka pehu i loko o ke koko i ka pō, ʻoi loa ka pō a i ʻole ka ʻōpū.
Ka mea i pane ʻole ʻia ma hypoglycemic a i ʻole ka hyperglycemic hopena e hiki ai ke nalowale i ka ʻike, coma, a i ʻole ka make.
Hoʻololi paha nā ʻano hōʻailona o nā mea o ka hypoglycemia a i ʻole hoʻi e haʻi ʻia me kahi papa lōʻihi o ka maʻi mellitus, diabetes neuropathy a i ʻole ka hoʻohana ʻana i nā lāʻau lapaʻau e like me beta-blockers.
ʻO ka hemahema a me ka wehe ʻole ʻana o ka hoʻōla, ʻoi aku hoʻi i nā mea maʻi me ka diabetes mellitus type 1, hiki ke alakaʻi ʻia i ka hyperglycemia a me ke ketoacidosis maʻi, nā kūlana e kūleʻa ai i ke ola ma ka mea maʻi.
Pono ke emi ʻana o ka insulin i nā poʻe maʻi me ka hiki ʻole o ka renal, a me nā mea a me nā mea i hōʻeha ʻia i ka ate me ka hōʻemi ʻana i nā kaʻina hana o ka gluconeogenesis a me ka metabolism insulin. Eia nō naʻe, i nā mea maʻi me ka mālama ʻole o ka puʻuwai, ʻoi aku ka nui o ka pale ʻana i ka insulin e alakaʻi i ka nui o ka pono no ka insulin.
Hiki paha ke hoʻonui i ka insulin me kekahi mau maʻi, a i ʻole ka luhi i ka naʻau.
Pono paha ka hoʻoponopono ʻana i ka dosis i ka wā e hoʻonui ai i nā maʻi i ka hoʻoikaika kino a i ke hoʻololi ʻana i ka ʻai maʻamau. Hiki i ke kōkō ke alakaʻi i ka nui o ka pilikia o ka hypoglycemia.
Ke hoʻohana nei i nā hoʻomākaukau no ka insulin e hui pū me nā lāʻau lapaʻau o ka pūʻulu thiazolidinedione, hoʻonui i ka hopena o ka hoʻomohala ʻana i ka edema a me ka pohō ʻole o ka puʻuwai naʻau, ʻo ia hoʻi i nā poʻe maʻi me nā maʻi o ka ʻōnaehana cardiovascular a me ka hele ʻana mai o nā mea pōpilikia no ka hiki ʻole o ka puʻuwai puʻuwai.
ʻO ka hoʻohana ʻana i ka laima Insulin lispro i nā keiki ma mua o ka hoʻonā mau ʻia ʻana o ka insulin kanaka i ʻoi aku i kēlā mau kūlana i ka wā e pono ai ke hoʻomaka koke i ka hana o ka insulin (no ka laʻana, ka hoʻomaka ʻana o ka insulin i mua o ka ʻai).
No ka pale aku i ka hoʻokae ʻia ʻana o kahi maʻi luhi, pono e hoʻohana ʻia kēlā me kēia kaʻaila / peni i hoʻokahi mea maʻi wale nō, ʻoiai ke hoʻololi ʻia ka pono.

Hoike ʻike

Ua kūʻai ʻia aku ka insulin Lyspro ma lalo o ka inoa inoa kālepa Humalog. Hiki ke kūʻai ʻia kēia lāʻau lapaʻau i loko o nā cartridges hypodermic a i ʻole nā pahu pale. ʻAʻole ia, e like me ka lāʻau lapaʻau i loko o nā cartridges, hiki ke hoʻokō i ka subcutaneously wale nō, akā komo pū kekahi a me ka intramuscularly. ʻOiai ka mea pono i hiki ke hoʻohui ʻia kēia lāʻau lapaʻau i loko o kahi syringe hoʻokahi me ka insulin hana lōʻihi, ʻoi aku ka maikaʻi o ka hana ʻana a hoʻohana i nā mea pākahi pilikino no kēlā me kēia hana hana. ʻO ka meaʻoiaʻiʻo nā mea hoʻohui a nā lāʻau lapaʻau e hiki ke komo i loko o kahi hopena i hopohopo ʻole a alakaʻi i nā hopena ʻaoʻao, alia, a me ka hōʻemi ʻana i ka hopena o nā mea ikaika.

Inā he maʻi maʻi ka mea āu e pono ai ke lawe pinepine i nā lāʻau lapaʻau ʻē aʻe, pono ʻoe e hoʻomaopopo i ka endocrinologist e pili ana i kēia. Ua kū ʻole ʻo Lyspro insulin i nā lāʻau lapaʻau kiʻekiʻe koko a me nā nui o ka ethanol. ʻO kona hopena hypoglycemic hiki ke hoʻemi nui i nā lāʻau lapaʻau hormonal no ka mālamaʻana i ka kelepa thyroid, nā lāʻau psychotropic a me kekahi diuretics (diuretics).

Hiki i kēia lāʻau lapaʻau ke mālama i nā maʻi me nā ʻano like ʻole o nā maʻi. E like me ke kānāwai, ua hoʻomanawanui maikaʻi a ʻike pinepine ʻia nā hopena ʻaoʻao. ʻO nā mea nui no ka hoʻohana ʻana iā ia:

type type 1 type (i nā mea maʻi me ka palaka maikaʻi ʻole i nā hoʻomākaukau insulin ʻē aʻe),
ʻO ka hoʻonui o ke kō ma hope o ka ʻai ʻana i hiki ʻole ke hoʻoponopono ʻia e nā ʻano lāʻau ʻē aʻe.
ʻAno maʻi 2 maʻamau
ʻano laikini type 2 o ke kaumaha hōʻeha, i hoʻolako ʻia ʻaʻole lawa ka hopena o ke kōpaʻa hāʻule ʻana i ke kō.
ka pale ʻana o nā hoʻopiʻi ʻana i nā maʻi me ka maʻi maʻi o kekahi ʻano me ka hana hoʻokūkū koʻikoʻi.

Mahalo i nā molekikini hormone hoʻololi i kēia lāʻau lapaʻau, hōʻike ʻo Humalog i kahi hopena pharmacological lawa a hiki i kēia māhele o nā maʻi maʻi.

Nā hiʻohiʻona noi

Pono e koho ʻia e ka haukapila o ka inane o lyspro e nā kauka, no ka mea he ʻokoʻa ia no kēlā me kēia maʻi. ʻO ka palena wale nō ʻoi aku ma mua o nā ʻāpana 40 o ka lāʻau lapaʻau ʻaʻole hiki ke lawelawe ʻia i ka manawa hoʻokahi. Ke puka nei i ke ʻano i ʻōlelo ʻia i hiki ke alakaʻi i ka hypoglycemia, maʻi pākē a i ʻole hoʻoiho kino i ke kino.

Pono e hoʻolako ʻia ka lāʻau lapaʻau ma mua o ka papaʻaina o nā manawa 4-6 i ka lā. Inā hoʻomaʻamaʻa ʻia ka mea maʻi me ka insulin lōʻihi e hana ana, hiki ke hoʻemi ʻia ka lōʻihi o ka hoʻokele ʻana i ka lāʻau Humalog i 1-3 mau manawa, e like me ka pae o ke kō i loko o nā manawa like ʻole o ka lā a me nā hiʻohiʻona o ka papa o ka maʻi maʻi.

Nā hiʻohiʻona a me nā hopena ʻaoʻao

ʻO kēia wale nō ka contraindication waha o ka lyspro insulin he hypoglycemia. I ka wā hāpai a me ka lactation, ua kauoha ʻia kēia lāʻau lapaʻau ma hope o ka nīnau ʻana i ka obstetrician-gynecologist. Ma muli o nā hiʻohiʻona o ka kino o ke kino o ka wahine, ke loli paha ka pono o ka mea maʻi i ka wā e kali ana i kahi keiki, no laila, koi ʻia ka hoʻoponopono ʻana a i ʻole wā hoʻihoʻi i ka lāʻau i kekahi manawa. ʻAʻole ʻike ʻia inā hoʻokomo ʻia ka lāʻau i ka waiū umauma, no ka mea, ʻaʻohe mau aʻo ʻana e pili ana i kēia kumuhana.

ʻO nā hopena kūpono i ka mālama ʻana i kēia lāʻau hānai pinepine. Akā hiki i kekahi manawa nā mea maʻi e ʻike:

haʻahaʻa haʻahaʻa haʻahaʻa ma lalo o ka pae kiʻekiʻe,
ka ʻūhū a me nā pilikia ʻole i ka pūnaewele injection,
huialohaʻi,
ʻohiʻala.

ʻO ka insulin Biphasic

Aia kahi hui pū kekahi i loaʻa i ka lālani insulin ponoʻī (kahi ʻenehana ultrashort) a me ka pale ʻana o ka protamine o kēia ʻano, he manawa maʻamau ka hana. ʻO ka inoa kālepa no kēia lāʻau lapaʻau ʻo Humalog Mix.

No ka loaʻa ʻana o kēia huahana ma ke ʻano o ka pakanika (ʻo ia hoʻi, nā wai ʻai me nā hapa liʻiliʻi liʻiliʻi i hoʻopili ʻole ʻia i loko) Mai hoʻoikaika ikaika i ka ipu, no ka mea hiki i kēia ke alakaʻi i ka pahuhopu a me ka hoʻopiʻi i ka pākuʻina o ka ʻāpana hoʻopaʻa.

E like me kēlā me kēia lāʻau lapaʻau no ka maʻi maʻi ʻokoʻa, pono e kuhikuhi ʻia e ke kauka kahi ʻano lua a ʻelua. Ma lalo o ka kaohi o ka hoʻokolohua o ke koko, hiki iā ʻoe ke koho i ka maʻa pono o ka lāʻau lapaʻau, hiki iā ʻoe ke mālama i ka mea maʻi ma ka hoʻomaʻamaʻa ʻana a me ka hoʻēmi ʻana i ka hoʻoulu ʻana i nā hoʻopiʻi o nā maʻi. ʻAʻole hiki iā ʻoe ke hoʻololi ʻokoʻa i ka hoʻololi kino ʻana i kahi ʻano like o ka insulin, no ka mea hiki i kēia ke hōʻeha i ke kaumaha no ke kino a hiki i ka pau ʻana.

Hoʻokomo i ka hiki ke lawe i nā kaʻa, nā mīkini

Me ka hypoglycemia a i ʻole hyperglycemia i hoʻopili ʻia me kahi regimen dole i nele, hiki ʻole i ka hiki ke hōʻemi a me ka wikiwiki o ka hopena psychomotor. Hiki i kēia mea ke lilo i mea e pilikia ai nā hana koʻikoʻi (me ka lawe ʻana i nā kaʻa a i ʻole nā mīkini).
Pono e mālama nā mea maʻi e pale aku i ka hypoglycemia i ke kaʻa. He mea koʻikoʻi loa kēia no nā maʻi i loaʻa kahi hōʻemi a i ʻole nā kaohi o nā hōʻailona ma mua o ka hypoglycemia, a i nā mea maʻamau ka maʻi hypoglycemia. I kēia mau kūlana, pono ia e nānā i ka hiki o ke kaʻa kaʻa a me ka hana hoʻokūkū.

E hoʻokuʻu i ke ʻano

ʻO ka hoʻonā ʻana no ka hoʻokele intravenous a me ka subcutaneous o 100 IU / ml.
3 ml o ka lāʻau i loko o kahi pahu kī o ka aniani māmā, ʻokoʻa ʻole (type I). Hoʻopili ʻia ka pahu pahu pahu ma kahi ʻaoʻao me kahi mea halihali bromobutyl a kiki ʻia i kahi pōpoki alumini, ma kahi ʻaoʻao ʻē aʻe me kahi brheloutyl plunger. Hoʻokomo ʻia 1 a i ʻole 5 mau pahu kāwili i kahi pōpō palu blister o ka PVC kiʻi a me ka alumini foil. Hoʻomoʻa i ke kāʻei pepa palula a me nā ʻōlelo no ka hoʻohana ʻana i waiho ʻia i loko o kahi pahu pepa. 10 ml o ka lāʻau lapaʻau i loko o kahi pahu aniani o ke aniani a me ka aniani, kīwaha (type I) me kahi kuʻi bromobutyl a kāpīpī ʻia me ka pāpala alumini.
1 ka pahu pahu me nā kauoha no ka hoʻohana ʻana i kahi pahu pahu.